Basal Cell Carcinoma (BCC)

DBCOND0040396NeoplasmsSkin and Subcutaneous Tissue Diseases

Basal Cell Carcinoma (BCC) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Basal Cell Carcinoma · Basal Cell Carcinomas · BCC - Basal Cell Carcinoma
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0003431SNOMED CT1338007MedDRA10004146UMLSC0007117

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
208Clinical trialsPhase, status and sponsor resolved per trial
Sign in
16Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Basal Cell Carcinoma (BCC) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In